Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-09-20 Purchase | 2021-09-22 6:48 pm | TScan Therapeutics Inc. | TCRX | MacBeath Gavin Chief Scientific Officer | 5,000 | $6.2193 | $31,097 | 49,767 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-13 Option Award | 2023-06-15 6:08 pm | N/A 2033-06-12 | TScan Therapeutics Inc. | TCRX | MacBeath Gavin Chief Executive Officer | 1,121,300 | $0 | 1,121,300 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 5:16 pm | N/A 2033-02-01 | TScan Therapeutics Inc. | TCRX | MacBeath Gavin See Remarks | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-07-25 Option Award | 2022-07-27 4:30 pm | N/A 2032-07-24 | TScan Therapeutics Inc. | TCRX | MacBeath Gavin See Remarks | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 4:26 pm | N/A 2032-01-17 | TScan Therapeutics Inc. | TCRX | MacBeath Gavin Chief Scientific Officer | 140,000 | $0 | 140,000 (Direct) | View |
Ownership | 2021-07-15 6:16 pm | N/A N/A | TScan Therapeutics Inc. | TCRX | MacBeath Gavin Chief Scientific Officer | 0 | $0 | 299,221 (Direct) | View |